Mounjaro, Zepbound May Lower Risk of Eye Disease in People With Diabetes
Weight loss medications Mounjaro and Zepbound, which contain the active ingredient tirzepatide, may lower the risk of diabetic retinopathy. Sponsored by February 21, 2026 TODAY'S TOP STORY Mounjaro, Zepbound May Lower Risk of Eye Disease in People With Diabetes READ ON U.S. May Lose Measles-Free Status Amid Outbreaks in South Carolina, Other States READ ON 8 Best Vitamins for Kids in 2026: Dietitians Weigh In READ ON ...